Scientists Call for a Moratorium on Editing Inherited Genes
By Karen Weintraub,
Scientific American [cites CGS' Marcy Darnovsky]
| 03. 13. 2019
A group of 18 prominent scientists—including some who helped develop CRISPR–Cas9, the current leading tool for gene editing—issued a call Wednesday for an international moratorium on gene edits to eggs, sperm or embryos, and for establishing a process to discuss how and whether it should ever occur again.
The move follows Chinese scientist He Jiankui’s announcement late last year that he had edited the genes of twin newborn girls, in attempt to make them genetically resistant to HIV. This was CRISPR’s first known use in human embryos destined for life. There had been a general global consensus to hold off on editing human eggs, sperm or embryos until gene-editing technology (and the implications of the edits) are better understood. But He’s decision to proceed—and some scientists’ focus on gaining regulatory approval rather than achieving societal consensus—showed clearer lines have to be drawn, says commentary co-author Eric Lander, president and founding director of the Broad Institute of MIT and Harvard, a genetics research institute.
Lander says the group is calling for a temporary moratorium as a first step. What the scientists...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...